Ken Fisher’s British American Tobacco BTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.45M Sell
76,166
-1,879
-2% -$111K ﹤0.01% 476
2025
Q4
$4.42M Buy
78,045
+5,298
+7% +$289K ﹤0.01% 480
2025
Q3
$3.86M Buy
72,747
+492
+0.7% +$26.7K ﹤0.01% 502
2025
Q2
$3.42M Buy
72,255
+22,720
+46% +$1.01M ﹤0.01% 528
2025
Q1
$2.05M Buy
49,535
+2,926
+6% +$115K ﹤0.01% 579
2024
Q4
$1.69M Buy
46,609
+11,914
+34% +$430K ﹤0.01% 604
2024
Q3
$1.27M Buy
34,695
+19,249
+125% +$688K ﹤0.01% 638
2024
Q2
$478K Buy
15,446
+1,316
+9% +$40K ﹤0.01% 793
2024
Q1
$431K Buy
14,130
+763
+6% +$23K ﹤0.01% 795
2023
Q4
$392K Sell
13,367
-10,138
-43% -$308K ﹤0.01% 815
2023
Q3
$403K Buy
23,505
+8,157
+53% +$269K ﹤0.01% 877
2023
Q2
$510K Buy
15,348
+3,686
+32% +$126K ﹤0.01% 866
2023
Q1
$411K Sell
11,662
-1,564
-12% -$59K ﹤0.01% 873
2022
Q4
$529K Buy
13,226
+2,185
+20% +$85.9K ﹤0.01% 831
2022
Q3
$392K Buy
11,041
+748
+7% +$30K ﹤0.01% 780
2022
Q2
$442K Sell
10,293
-1,327
-11% -$56.9K ﹤0.01% 734
2022
Q1
$490K Buy
11,620
+182
+2% +$7.76K ﹤0.01% 736
2021
Q4
$428K Buy
11,438
+2,519
+28% +$89.4K ﹤0.01% 790
2021
Q3
$315K Buy
8,919
+304
+4% +$11.4K ﹤0.01% 789
2021
Q2
$339K Sell
8,615
-521
-6% -$20.4K ﹤0.01% 784
2021
Q1
$354K Sell
9,136
-3,828
-30% -$144K ﹤0.01% 758
2020
Q4
$486K Buy
12,964
+597
+5% +$21.4K ﹤0.01% 714
2020
Q3
$447K Buy
12,367
+264
+2% +$9.24K ﹤0.01% 678
2020
Q2
$470K Sell
12,103
-2,901
-19% -$111K ﹤0.01% 662
2020
Q1
$513K Sell
15,004
-302
-2% -$12.3K ﹤0.01% 613
2019
Q4
$650K Buy
15,306
+3,199
+26% +$121K ﹤0.01% 632
2019
Q3
$447K Buy
12,107
+567
+5% +$20.7K ﹤0.01% 703
2019
Q2
$402K Buy
11,540
+349
+3% +$13.2K ﹤0.01% 697
2019
Q1
$467K Buy
11,191
+874
+8% +$31.8K ﹤0.01% 648
2018
Q4
$329K Buy
10,317
+1,166
+13% +$45.4K ﹤0.01% 710
2018
Q3
$427K Sell
9,151
-1,102
-11% -$56K ﹤0.01% 672
2018
Q2
$517K Sell
10,253
-605
-6% -$31.9K ﹤0.01% 637
2018
Q1
$626K Buy
10,858
+1,493
+16% +$93.9K ﹤0.01% 600
2017
Q4
$627K Buy
9,365
+525
+6% +$34.2K ﹤0.01% 627
2017
Q3
$552K Buy
8,840
+5,057
+134% +$326K ﹤0.01% 621
2017
Q2
$259K Sell
3,783
-630
-14% -$43.8K ﹤0.01% 669
2017
Q1
$293K Buy
4,413
+615
+16% +$38.1K ﹤0.01% 632
2016
Q4
$214K Sell
3,798
-1,350
-26% -$76.5K ﹤0.01% 677
2016
Q3
$329K Buy
5,148
+1,840
+56% +$117K ﹤0.01% 619
2016
Q2
$212K Sell
3,308
-478
-13% -$28.9K ﹤0.01% 655
2016
Q1
$228K Sell
3,786
-992
-21% -$54.6K ﹤0.01% 641
2015
Q4
$264K Buy
4,778
+128
+3% +$7.34K ﹤0.01% 640
2015
Q3
$256K Sell
4,650
-2,036
-30% -$113K ﹤0.01% 609
2015
Q2
$362K Sell
6,686
-376
-5% -$20.7K ﹤0.01% 487
2015
Q1
$366K Sell
7,062
-636
-8% -$35.3K ﹤0.01% 475
2014
Q4
$415K Buy
7,698
+570
+8% +$32K ﹤0.01% 467
2014
Q3
$403K Sell
7,128
-3,860
-35% -$228K ﹤0.01% 454
2014
Q2
$654K Sell
10,988
-4,192
-28% -$246K ﹤0.01% 414
2014
Q1
$846K Sell
15,180
-20,884
-58% -$1.09M ﹤0.01% 384
2013
Q4
$1.94M Sell
36,064
-1,184,498
-97% -$63M ﹤0.01% 350
2013
Q3
$64.2M Sell
1,220,562
-5,630,606
-82% -$298M 0.16% 105
2013
Q2
$353M Buy
+6,851,168
New +$377M 0.92% 44

Other funds holding BTI

Ken Fisher's BTI Position: Q1 2026 in Review

Ken Fisher reduced its British American Tobacco (BTI) stake by 2.4% in Q1 2026, selling an estimated $111K and leaving 76,166 shares worth $4.45M. The position accounts for ﹤0.01% of the portfolio, ranked #476.

Ken Fisher first reported a position in BTI in Q2 2013 and has held it in 52 quarters since. The position peaked at $353M in Q2 2013. 866 funds tracked by Wall St. Rank hold BTI as of Q1 2026.

  • Ken Fisher held 76,166 shares of British American Tobacco worth $4.45M as of Q1 2026.
  • Ken Fisher sold 1,879 British American Tobacco shares in Q1 2026, an estimated $111K.
  • British American Tobacco made up ﹤0.01% of Ken Fisher's portfolio in Q1 2026, its #476 holding.
  • Ken Fisher first reported a position in British American Tobacco in Q2 2013 and has held it in 52 quarters since.
  • Ken Fisher's British American Tobacco position peaked at $353M in Q2 2013.
  • 866 funds tracked by Wall St. Rank held British American Tobacco as of Q1 2026.

Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.